No False Advertising Found: US Court Rejects Bayer Plea to Block Johnson and Johnson's Erleada Ads sheeba farhat18 April 2026 7:22 PM ISTNew York: A U.S. judge has rejected Bayer's request for an injunction to block Johnson & Johnson's alleged false advertising that its...
Amazon Enters Drug Discovery Race with AI Platform for Faster Molecule Design sheeba farhat15 April 2026 7:13 PM ISTBengaluru: Amazon's cloud unit on Tuesday launched Amazon Bio Discovery, an artificial intelligence application designed to speed early-stage drug...
Finerenone Slows Kidney Function Decline in Non-Diabetic CKD: Phase III FIND-CKD study Dr. Kamal Kant Kohli19 March 2026 9:00 PM ISTThe Phase III FIND-CKD trial demonstrated that finerenone (Kerendia), when added to standard care, significantly reduced the rate of kidney function...
Bayer Moves Court Against J&J Over Misleading Advertising on Cancer Drug Erleada sheeba farhat26 Feb 2026 9:08 PM ISTBayer said Johnson & Johnson falsely claimed that patients treated with Erleada had a "51% reduction in ​risk of death" compared with Nubeqa patients,...
Bayer Finerenone approved in Japan for chronic heart failure Ruchika Sharma22 Dec 2025 10:30 AM ISTBerlin: Bayer has received approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for finerenone (Kerendia), a non-steroidal, selective...
Biocon Biologics signs settlement, license agreement to commercialize biosimilar Aflibercept worldwide Ruchika Sharma14 Dec 2025 4:30 PM ISTBengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced a new settlement...
Bayer-Regeneron Aflibercept 8 mg recommended for EU approval for third retinal indication Ruchika Sharma14 Dec 2025 2:00 PM ISTBerlin: Bayer has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended...
Bayer AskBio receive Pioneering Regenerative Medical Product Designation for gene therapy programs in Japan Ruchika Sharma10 Dec 2025 3:40 PM ISTBerlin: AskBio, a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has announced that Japan's Ministry...
Bayer begins Phase IIa trial of BAY 3401016 for Alport Syndrome Ruchika Sharma7 Dec 2025 10:30 AM ISTBerlin: Bayer has announced initiation of a Phase IIa clinical trial with BAY 3401016, an investigational monoclonal antibody with potential to...
Bayer begins Phase III study with Mirena for nonatypical endometrial hyperplasia Ruchika Sharma2 Dec 2025 10:30 AM ISTBerlin: Bayer has announced the clinical Phase III study SUNFLOWER with its 52mg levonorgestrel-releasing intrauterine system (LNG-IUS) Mirena....
Bayer Hyrnuo secures USFDA accelerated approval for previously treated advanced HER2 mutant non small cell lung cancer Ruchika Sharma21 Nov 2025 1:30 PM ISTBerlin: Bayer has received accelerated approval from the U.S. Food and Drug Administration (FDA) for HYRNUO (sevabertinib),for the treatment of...
Bayer Lynkuet approved in EU for hot flashes Ruchika Sharma20 Nov 2025 10:30 AM ISTBerlin: Bayer has announced that the European Commission has granted marketing authorization in the European Union (EU) for elinzanetant, under...
